方盛制药股价涨5.32%，国泰基金旗下1只基金位居十大流通股东，持有300万股浮盈赚取198万元

Core Viewpoint - Fangsheng Pharmaceutical has experienced a significant stock price increase, with a 5.32% rise on November 14, reaching 13.06 CNY per share, and a total market capitalization of 5.734 billion CNY. The stock has risen for six consecutive days, accumulating a total increase of 5.35% during this period [1]. Company Overview - Fangsheng Pharmaceutical Co., Ltd. is located in Changsha, Hunan Province, and was established on October 13, 1997. The company was listed on December 5, 2014. Its main business includes the research, production, and sales of traditional Chinese medicine for cardiovascular and cerebrovascular diseases, orthopedic medicine, pediatric medicine, and anti-infection drugs. The revenue composition is 94.62% from product sales and 5.38% from services [1]. Shareholder Insights - Guotai Fund's Guotai Jinniu Innovation Growth Mixed Fund (020010) has entered the top ten circulating shareholders of Fangsheng Pharmaceutical, holding 3 million shares, which is 0.68% of the circulating shares. The fund has gained approximately 1.98 million CNY in floating profit today and 1.89 million CNY during the six-day price increase [2]. Fund Performance - Guotai Jinniu Innovation Growth Mixed Fund (020010) was established on May 18, 2007, with a current size of 1.494 billion CNY. Year-to-date returns are 43.83%, ranking 1608 out of 8140 in its category, while the one-year return is 34.22%, ranking 1713 out of 8056. Since inception, the fund has achieved a return of 403.92% [2]. Top Holdings - Another fund under Guotai, Guotai Juli Value Periodic Open Flexible Allocation Mixed Fund (005746), holds 89,900 shares of Fangsheng Pharmaceutical, accounting for 0.51% of the fund's net value. The fund has gained approximately 59,300 CNY in floating profit today and 56,600 CNY during the six-day price increase [4]. Fund Manager Information - The fund manager for both Guotai Jinniu and Guotai Juli is Cheng Zhou, who has a cumulative tenure of 17 years and 230 days, managing assets totaling 7.788 billion CNY. The best fund return during his tenure is 368.13%, while the worst is -37% [3][5]. Cheng Yao, co-manager of Guotai Juli, has a tenure of 4 years and 130 days, with a best return of 15.89% and a worst return of 5% [5].